Document is current
Any future updates will be listed below
-
Authors
Zhang, Bing
Magnaye, Kevin M.
Stryker, Emily
Moltzau-Anderson, Jacqueline
Porsche, Cara E.
Hertz, Sandra
McCauley, Kathryn E.
Smith, Byron J.
Zydek, Martin
Pollard, Katherine S.
Ma, Averil
El-Nachef, Najwa
Lynch, Susan V.
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK007007)
National Institute of General Medical Sciences (K12 GM081266-11)
National Science Foundation (1563159)
Chan Zuckerberg Biohub
Gladstone Institutes
Kenneth Rainin Foundation
Crohn’s and Colitis Foundation
- License Information
-
More Information
Article History
Received: 12 September 2023
Accepted: 16 May 2024
First Online: 9 August 2024
Competing interests
: SVL is co-founder and shareholder of Siolta Therapeutics, Inc. and serves as both a consultant and a member of its Board of Directors. KSP is on the scientific advisory board of Phylagen. NE-N has received research support from Finch Therapeutics and Assembly Biosciences and has been a consultant for Federation Bio and Ferring Pharmaceuticals. All other authors declare no competing interests.
